Top300 Bio CDMO:設施索引和生物製造商註冊資料庫
年間契約型資訊服務
商品編碼
1455820

Top300 Bio CDMO:設施索引和生物製造商註冊資料庫

Top300 Bio CDMO - Facility Index and Biomanufacturers Subscription Database

出版日期: 年間契約型資訊服務 | 出版商: BioPlan Associates, Inc. | 英文

價格
簡介目錄

該資料庫是世界上唯一一個積極追蹤400 多家提供生物製藥開發和製造服務的公司的 CDMO 設施的合約開發和製造設施資料庫。

全球有數百家工廠以臨床和商業規模生產生物製劑,到 2023 年,它們總共將產生 168.9 億美元的服務收入每年增長 17%。

該資料庫基於30 年的生物製藥和生命科學行業評估和基準,不斷更新以包含全面的資訊和見解。

"Top300 Bio CDMO 設施指數" 對每個 "專用" CDMO 設施進行排名,並按區域提供生物製造區域/柵格的定量分析。

  • 生物反應器總容量
  • CDMO/CMO服務專業知識
  • 生物製造產能計畫未來投產
  • 目前正在生產的商業和臨床生物製藥產品數量
  • 收入預測
  • 優勢/挑戰
  • 技術和專業知識等

如何使用top300biocdmo.com

  • 確定理想的 CDMO或合作夥伴
  • 確定您的專長:細胞治療、基因治療、pDNA、mRNA 等。
  • 早期公司:贊助商識別潛在的製造合作夥伴
  • 設施選址:確保優秀員工並減少就業問題
  • 分配銷售區域:決定區域的位置和人員配置
  • 市場競爭:識別 CDMO 競爭對手的優勢和劣勢
  • 房地產評估:基於設施相關和區域吸引力
  • 人力資源和招募經理:確定所需的受過高等教育和技術熟練的員工的最低數量
  • 產業成長:尋找產業成長最快的地區
  • 新興地區:中國、印度、拉丁美洲和中東的 CDMO 設施
  • CDMO公司排名: CDMO設施在技能、就業和生產能力方面的排名
簡介目錄

The only Global Contract Development and Manufacturing Facilities Database subscription that actively tracks over 400+ dedicated CDMO facilities providing development and manufacturing services for biopharmaceuticals.

Hundreds of facilities manufacturing clinical and commercial scale biologics, account for $16.89 billion in services sales in 2023, growing at 17% annually.

Based on 30 years of evaluating and benchmarking the biopharmaceutical and life sciences industry, this database is updated continually and includes comprehensive information and insights.

"Top300 Bio CDMO Facility Index" ranks each 'dedicated' CDMO facility and provides regional quantitative analysis of biomanufacturing regions and clusters.

  • Total bioreactor liter capacity
  • CDMO/CMO service expertise
  • Future Biomanufacturing capacity coming online
  • Number of commercial and clinical biological products manufactured
  • Revenue estimates
  • Strengths and Challenges
  • Technologies and expertise, and much more

USES FOR THE TOP300BIOCDMO.COM

  • Identify your ideal CDMO or partners
  • Identify specialized expertise such as cell or gene therapy, pDNA, mRNA
  • Early-stage companies: sponsors can identify potential manufacturing partners
  • Facility siting: Locate qualified employees; reduce hiring challenges
  • Sales territory allocations: Determine where and how to staff territories
  • Market Competition: Identify CDMO competitors' strengths and weaknesses
  • Real estate valuation: For facilities, based on regional attractiveness
  • HR and Recruiters: Looking for a critical mass of educated and skilled staff
  • Industry Growth: Find where the industry is growing most rapidly
  • Emerging Regions: CDMO Facilities in China, India, Latin America, Middle East regions
  • CDMO Company Ranking: How do CDMO facilities rank, in skills, employment, capacity